News

PMLive10m
Johnson & Johnson’s TAR-200 granted FDA priority review to treat bladder cancer
Johnson & Johnson (J&J) has announced that its investigational intravesical gemcitabine releasing system has been accepted ...
PMLive12m
NICE recommends BeOne’s Brukinsa to treat mantle cell lymphoma on NHS
The National Institute for Health and Care Excellence (NICE) has recommended BeOne Medicines’ targeted cancer drug Brukinsa ...
PMLive14m
Alnylam’s Amvuttra approved by MHRA to treat rare heart disease ATTR-CM
Alnylam Pharmaceuticals’ Amvuttra (vutrisiran) has been approved by the Medicines and Healthcare products Regulatory Agency ...